Clinical Trials on Transient Global Amnesia in Russian Federation

Total 100 results

Bakulev Scientific Center of Cardiovascular Surgery

Recruiting

Radiofrequency and Cryoablation of the Posterior Wall of the Left Atrium

Stroke | Death | Transient Ischemic Attack | Acute Cerebrovascular Accident | Atrial Fibrillation Recurrent

Russian Federation
Istituto Auxologico Italiano
European Society of Hypertension; Chinese Hypertension League

Completed

Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives (ESH-CHL-SHOT)

Stroke | Hypertension | Transient Ischemic Attack

Russian Federation
I.M. Sechenov First Moscow State Medical University
NanoPass Technologies Ltd

Completed

Intradermal Lidocaine Via MicronJet600 Microneedle Device

Local Anaesthesia

Russian Federation
Eugene Nikitin

Unknown

Ibrutinib in Steroid Refractory Autoimmune Hemolytic Anemia (ISRAEL)

AIHA - Warm Autoimmune Hemolytic Anemia

Russian Federation
Federal Research Institute of Pediatric Hematology...

Recruiting

Eltrombopag+hATG+CsA vs. hATG+CsA in Children With Severe AA

Acquired Aplastic Anemia

Russian Federation
Federal Scientific Clinical Centre of Pediatric...

Unknown

L-leucine in Diamond Blackfan Anemia Patients

Diamond Blackfan Anemia

Russian Federation
Novartis Pharmaceuticals

Terminated

Safety and Efficacy of Exjade in the Treatment of Transfusion-dependent Iron Overload in Aplastic Anemia Patients

Aplastic Anemia

Russian Federation
I.M. Sechenov First Moscow State Medical University

Completed

Sedation and Memory Consolidation

Memory Impairment | Amnesia | Recall | Recognition

Russian Federation
Tomsk National Research Medical Center of the Russian...

Recruiting

The Prevalence of Iron Deficiency and the Effectiveness of Ferinject® in Patients With HFpEF (ID-HFpEF) (ID-HFpEF)

Chronic Heart Failure | Iron Deficiency, Latent

Russian Federation
Vifor Pharma
Parexel

Completed

Maintenance Treatment of Iron Deficiency in IBD Patients (FER-IBD-MAIN)

Iron Deficiency | Inflammatory Bowel Disease

Russian Federation
National Research Center for Hematology, Russia

Unknown

Russian Clinical Trial of Mesenchymal Cells in Patients With Septic Shock and Severe Neutropenia

Septic Shock | Nonchemotherapy Drug-induced Neutropenia | Neutropenia After Chemotherapy in Oncohematological Patients | Neutropenia in Patients With Aplastic Anemia

Russian Federation
Meshalkin Research Institute of Pathology of Circulation

Completed

Choice of Palliative Procedures for Pulmonary Atresia With Ventricular Septal Defect Patients

Pulmonary Atresia With Ventricular Septal Defect | Tetralogy of Fallot With Pulmonary Atresia

Russian Federation
Federal Research Institute of Pediatric Hematology...

Unknown

the Efficacy and Safety of Sugammadex in Children 0-2 Years Old

Anesthesia | Pediatric Cancer | Beta-Thalassemia | Hepatic Metastases | Pediatric Tumor | Pediatric Hepatoblastoma

Russian Federation
Petrovsky National Research Centre of Surgery

Completed

Efficiency and Safety a Fixed Combination of Orphenadrine and Diclofenac for Postoperative Analgesia

Analgesia

Russian Federation
Burnasyan Federal Medical Biophysical Center

Unknown

Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis

Neutropenic Enterocolitis | Myeloablative Chemotherapy Induced Bone Marrow Aplasia

Russian Federation
Kazan State Medical University

Recruiting

An Open Study on the Efficacy of Iron Therapy Using iv Iron Relative to Oral Iron for Increasing LV Systolic Function (OPERA-MI)

Myocardial Infarction | Iron-deficiency

Russian Federation
Vifor Pharma
ICON Clinical Research

Completed

A Study to Compare the Use of Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Iron Deficiency (CONFIRM-HF)

Chronic Heart Failure | Iron Deficiency

Poland, Russian Federation
Biocad

Completed

Clinical Trial of BCD-148 and Soliris® for the Treatment of Patients With Paroxysmal Nocturnal Hemoglobinuria

Paroxysmal Nocturnal Hemoglobinuria

Russian Federation
Northern State Medical University
University of Tromso

Completed

Single Transpulmonary Thermodilution and Continuous Monitoring of Central Venous Oxygen Saturation During Off-pump Coronary Surgery (OPCAB)

Coronary Artery Disease | Hemodynamic Monitoring | Goal Directed Therapy

Russian Federation
Sandoz

Completed

Study to Test the Hypothesis of Non-inferior Efficacy and Safety of Ferrum Lek® (Iron (III) Hydroxide Polymaltosate), 100 mg Chewable Tablets (Lek d.d., Slovenia), as Compared With MALTOFER® (Vifor S.A., Switzerland), in Subjects With Mild and Moderate Iron Deficiency Anemia.

Mild and Moderate Iron-deficiency Anaemia

Russian Federation
Novartis Pharmaceuticals

Completed

This Study Will Evaluate Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndromes (MDS), Thalassemia and Rare Anemia Types Having Transfusion-induced Iron Overload.

Myelodysplastic Syndrome | Thalassemia

Russian Federation
Pirogov Russian National Research Medical University

Completed

Fluid Overload and Pulmonary Function

Critical Illness | Respiratory Failure | Water-Electrolyte Imbalance | Pediatric | Esophageal Atresia | Length of Stay | Intensive Care Units

Russian Federation
University of Bergen

Completed

Therapy for Chronic Cold Agglutinin Disease

Cold Agglutinin Disease

Norway, Russian Federation
AO GENERIUM

Completed

Efficacy and Safety of Elizaria® vs. Soliris® in Patients With PNH

Paroxysmal Nocturnal Hemoglobinuria | Marchiafava-Micheli Syndrome | Paroxysmal Hemoglobinuria

Russian Federation
Biocad

Completed

Comparative Study of the Efficacy and Safety of BCD-131 and Mircera in Treatment of Anemia in CKD Patients on Dialysis

Anemia

Russian Federation, Belarus
American Regent, Inc.

Completed

A Study to Characterize the PK and PD Profile of IV FCM in Pediatric Subjects 1-17 Years Old With IDA

Iron Deficiency Anemia (IDA)

Poland, Russian Federation
AO GENERIUM

Completed

Observational Study of Elizaria® in aHUS Patients

Atypical Hemolytic Uremic Syndrome | aHUS

Russian Federation
Russian Academy of Medical Sciences

Completed

Intranasal Inhalations of Bioactive Factors Produced by M2 Macrophages in Patients With Organic Brain Syndrome

Neurocognitive Disorders | Brain Ischemia | Delirium, Dementia, Amnestic, Cognitive Disorders | Organic Brain Syndrome, Nonpsychotic | Mental Disorder, Organic | Nonpsychotic Organic Brain Syndrome | Organic Mental Disorder | Encephalopathy, Post-Traumatic, Chronic | Encephalopathy, Ischemic

Russian Federation
Shenyang Sunshine Pharmaceutical Co., LTD.
Navitas Life Sciences GmbH

Completed

Biosimilar Erythropoietin in Anaemia Treatment (Maintenance Phase Study) (BEAT_002)

Renal Anemia

Thailand, Russian Federation
Eurasian Association of Therapists

Completed

Analysis of Health Status of Сomorbid Adult Patients With COVID-19 Hospitalised in Fourth Wave of SARS-CoV-2 Infection (ACTIV4)

Myocardial Infarction | Stroke | COVID-19 | Diabetes Mellitus | Chronic Kidney Diseases | Ischemic Stroke | Anemia | Atrial Fibrillation | Asthma | Myocarditis | Ischemic Heart Disease | Chronic Heart Failure | Copd | Overweight and Obesity | Pulmonary Embolism | Oncology | Arrythmia | DVT | Hypertensive Heart Disease

Russian Federation
Hoffmann-La Roche

Completed

A Study of Intravenous Mircera in Dialysis Patients With Chronic Renal Disease and Anemia.

Anemia

Russian Federation
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Pulmonary Hypertension, Hypoxia and Sickle Cell Disease

Sickle Cell Anemia | Pulmonary Hypertension | Cerebrovascular Disease | Chuvash Polycythemia

United States, Russian Federation
FibroGen
Astellas Pharma Inc

Completed

Study of Roxadustat (FG-4592) to Correct Anemia in Newly Initiated Dialysis Participants Not on Erythropoiesis-Stimulating Agent Treatment

Anemia | Dialysis

Hong Kong, United States, Singapore, Russian Federation
Hoffmann-La Roche

Completed

A Study of Subcutaneous C.E.R.A. for the Treatment of Anemia in Pre-Dialysis Patients.

Anemia

Russian Federation
Affymax
Takeda

Completed

Safety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving an ESA

Anemia | Chronic Kidney Disease | Chronic Renal Failure

Russian Federation
AstraZeneca

Completed

THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death (THALES)

Acute Ischaemic Stroke | Transient Ischaemic Attack

Belgium, France, Italy, Spain, Sweden, Thailand, Germany, Korea, Republic of, Brazil, Hungary, India, Mexico, Vietnam, China, Taiwan, Hong Kong, Slovakia, Australia, Poland, Saudi Arabia, Ukraine, Canada, Russian Federation, Bulgaria, R... and more
Alexion

Completed

A Study of Ravulizumab (ALXN1210) in Children and Adolescents With Paroxysmal Nocturnal Hemoglobinuria

Paroxysmal Nocturnal Hemoglobinuria

France, United Kingdom, Norway, Russian Federation, Netherlands, United States
AstraZeneca

Completed

LINE: Treatment Patterns in postmenopausaL Women With Hormone Receptor Positive Breast Cancer (LINE)

Local Advanced or Metastatic Postmenopausal Breast Cancer

Russian Federation
Hoffmann-La Roche

Completed

A Study of the Quality of Life and Treatment Response to Once Weekly Epoetin Beta (Recormon) Treatment in Anemic Participants With Solid and Lymphoid Malignancies

Anemia

Russian Federation
AstraZeneca

Completed

[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES] (SOCRATES)

Acute Ischaemic Stroke | Transient Ischaemic Attack

Sweden, United States, Australia, Brazil, Bulgaria, France, Italy, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Turkey, Vietnam, Germany, Philippines, China, Hungary, Romania, Ukraine, Hong Kong, Argentina, Bel... and more
AO GENERIUM

Completed

A Safety and Immunogenicity Study in Long-term Treatment of Eculizumab (JSC "GENERIUM", Russian Federation) (NAP)

Paroxysmal Nocturnal Hemoglobinuria

Russian Federation
Beijing Tiantan Hospital
Ministry of Science and Technology of the People´s Republic of China

Completed

Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II (CHANCE-2)

Stroke | Transient Ischemic Attack

China
Watson Pharmaceuticals

Completed

Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients

Anemia

United States, Poland, Mexico, Serbia, Russian Federation
Biocad

Completed

Safety and Efficacy Study of BCD-066 Compared to Aranesp® for Anemia Treatment in Chronic Kidney Disease Patients

Anemia | Chronic Kidney Disease | End Stage Renal Failure on Dialysis

Russian Federation
AO GENERIUM

Completed

Prospective Observational Study of Long-term Pathogenic Treatment of Elizaria® (NAP)

Paroxysmal Nocturnal Hemoglobinuria

Russian Federation
Kezar Life Sciences, Inc.

Withdrawn

A Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP (MARINA)

Immune Thrombocytopenia | Autoimmune Hemolytic Anemia

Poland, United States, Australia, Italy, Russian Federation
Novartis Pharmaceuticals

Active, not recruiting

A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia

Aplastic Anemia

Thailand, Russian Federation, Portugal, United Kingdom, Hong Kong, United States
Bristol-Myers Squibb
Janssen, LP

Completed

A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel (AXIOMATIC-SSP)

Acute Ischemic Stroke | Transient Ischemic Attack (TIA)

France, Germany, Russian Federation, United States, China, Hong Kong, Korea, Republic of, Greece, Israel, Canada, Argentina, Australia, Austria, Belgium, Brazil, Chile, Czechia, Denmark, Finland, Hungary, Italy, Japan, Mexico, Norway, P... and more
Rigel Pharmaceuticals

Enrolling by invitation

A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

Warm Antibody Autoimmune Hemolytic Anemia

Spain, United States, Australia, Norway, Belarus, Germany, Netherlands, Belgium, Austria, Bulgaria, Czechia, France, Georgia, Italy, Russian Federation, Serbia, Ukraine, United Kingdom
Watson Pharmaceuticals

Completed

2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.

Iron Deficiency Anemia

United States, Canada, Mexico, Bulgaria, India, Russian Federation, Croatia, Poland

Clinical Trials on Transient Global Amnesia in Russian Federation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations